What is the recommended dose of prednisolone (corticosteroid) for various medical conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Prednisolone Dosing for Various Medical Conditions

The recommended prednisolone dosage varies by condition, with typical doses ranging from 0.3-2 mg/kg/day for most conditions, with higher doses (up to 60 mg/day) for severe conditions and lower doses (as little as 2.5-5 mg/day) for maintenance therapy. Dosing must be tailored to disease severity and patient characteristics.

Dermatological Conditions

Bullous Pemphigoid

  • Severe involvement: 0.75-1 mg/kg/day 1
  • Moderate disease: 0.5 mg/kg/day 1
  • Mild/localized disease: 0.3 mg/kg/day 1
  • Taper after disease control (typically 4 weeks): reduce by one-third or one-quarter down to 15 mg daily, then by 2.5 mg decrements to 10 mg daily, then by 1 mg monthly 1

Pemphigus Vulgaris

  • Initial therapy: 1-2 mg/kg/day 1
  • Milder cases may be treated with 0.5-1 mg/kg/day 1
  • If no response within 5-7 days, increase dose in 50-100% increments 1
  • Treatment failure defined as failure to achieve control despite 3 weeks of prednisolone 1.5 mg/kg/day 1
  • Consider pulsed IV methylprednisolone (10-20 mg/kg or 250-1000 mg) for severe cases 1

Pediatric Conditions

General Pediatric Dosing

  • Range of initial doses: 0.14-2 mg/kg/day in 3-4 divided doses (4-60 mg/m²/day) 2
  • Maximum dose generally capped at 60 mg/day for children 2

Nephrotic Syndrome in Children

  • Standard regimen: 2 mg/kg/day (maximum 60 mg/day) 2, 3
  • Maintenance: 60 mg/m²/day in three divided doses for 4 weeks, followed by 4 weeks of single-dose alternate-day therapy at 40 mg/m²/day 3

Asthma in Children

  • 1-2 mg/kg/day in single or divided doses until peak flow reaches 80% of personal best 2
  • Duration typically 3-10 days (no tapering necessary for short courses) 2

Rheumatological Conditions

Polymyalgia Rheumatica/Temporal Arteritis

  • Initial doses correlate with maintenance requirements 4
  • Maintenance dose: 5.7 mg/day (first year) and 4.3 mg/day (second year) for PMR 4
  • Maintenance dose: 6.6 mg/day (first year) and 4.1 mg/day (second year) for temporal arteritis 4
  • Low-dose long-term therapy (2-5 mg/day) may be effective for rheumatoid arthritis 5

Hepatic Conditions

Autoimmune Hepatitis

  • Initial dose: 40 mg daily or 0.6-0.8 mg/kg daily for first 4 weeks 2
  • In children: 2 mg/kg daily (up to 60 mg/day) 2

Alcoholic Hepatitis

  • 40 mg/day for 28 days, then tapered 2

Multiple Sclerosis

  • Acute exacerbations: 200 mg daily for one week, followed by 80 mg every other day for one month 3

Important Dosing Considerations

Tapering Guidelines

  • Never stop prednisolone abruptly due to risk of adrenal insufficiency 2
  • For long-term therapy, taper gradually:
    • Reduce by one-third or one-quarter down to 15 mg daily
    • Then by 2.5 mg decrements to 10 mg daily
    • Then by 1 mg monthly 1

Alternative Dosing Strategies

  • Twice-daily fractionated dosing may allow for lower total daily doses (2.5 mg/day vs. 4.0 mg/day) with similar efficacy and fewer side effects 6

Monitoring Requirements

  • Blood pressure at each visit
  • Glucose levels (urine dipstick)
  • Bone density for long-term use
  • Signs of infection, mood changes, sleep disturbances 2

Pitfalls and Caveats

  1. Steroid-related adverse effects: Dose-dependent immunosuppressive and metabolic effects occur with all regimens 1

  2. Relapse during tapering: About 50% of patients will relapse during dose reduction, indicating the previous dose was the minimal effective dose 1

  3. Individualized dosing: While individualization is important, evidence supports specific starting doses based on disease severity 1, 2

  4. Pulsed therapy: Monthly oral dexamethasone pulses showed no additional benefit and more adverse effects compared to conventional oral corticosteroids in pemphigus vulgaris 1

  5. Treatment failure: If standard doses fail, consider adjunctive immunosuppressive therapy rather than further increasing prednisolone dose 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.